Showing results (1451-1460 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|January 12, 2013
Discovery of N-Aryl Piperazines as Selective mGlu(5) Potentiators with Efficacy in a Rodent Model Predictive of Anti-Psychotic ActivityYa Zhou, Jason T Manka, Alice L Rodriguez, et al.
ACS Medicinal Chemistry Letters|January 15, 2013
3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibitionHuiping Zhao, Bin Yan, Laura B Peterson, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4Christian Schmitt, Parisa Miralinaghi, Marica Mariano, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activityElisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor ImagingJi-Ae Park, Yong Jin Lee, Ji Woong Lee, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Desmethyl macrolides: synthesis and evaluation of 4-desmethyl telithromycinIan Glassford, Miseon Lee, Bharat Wagh, et al.
ACS Medicinal Chemistry Letters|October 14, 2014
Structure-Activity Studies Reveal the Oxazinone Ring Is a Determinant of Cytochrome P450 2B6 Activity Toward EfavirenzPhilip M Cox, Namandjé N Bumpus
ACS Medicinal Chemistry Letters|October 15, 2014
Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structureYoshiki Hayashi, Haruka Takeno, Takumi Chinen, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB InhibitorBingbing X Li, Fuchun Xie, Qiuhua Fan, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 AgonistsStefan Peukert, Richard Hughes, Jill Nunez, et al.
Pageof 438